Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0005 USD
Change Today 0.00 / 0.00%
Volume 12.1M
As of 5:20 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

bio-matrix scientific group (BMSN) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/11/14 - $0.0048
52 Week Low
01/22/15 - $0.0004
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

bio-matrix scientific group (BMSN) Related Businessweek News

No Related Businessweek News Found

bio-matrix scientific group (BMSN) Details

Bio-Matrix Scientific Group, Inc., a development stage company, through its subsidiary, Regen BioPharma, Inc., intends to engage primarily in the development of regenerative medical applications. It develops HemaXellerate I, which is a patient-specific composition of cells that have been demonstrated to repair damaged bone marrow and stimulate production of blood cells based on previous animal studies. The company is based in La Mesa, California.

3 Employees
Last Reported Date: 12/29/14

bio-matrix scientific group (BMSN) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $300.0K
Compensation as of Fiscal Year 2014.

bio-matrix scientific group (BMSN) Key Developments

Bio-Matrix Scientific Group, Inc. announced delayed annual 10-K filing

On 12/30/2013, Bio-Matrix Scientific Group, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Bio-Matrix Scientific Group, Inc. announced delayed 10-Q filing

On 05/14/2013, Bio-Matrix Scientific Group, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMSN:US $0.00 USD 0.00

BMSN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BMSN.
View Industry Companies

Industry Analysis


Industry Average

Valuation BMSN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-MATRIX SCIENTIFIC GROUP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at